Skip to main content

GSK Licenses Jubilant s Pathway Database

NEW YORK, Jan. 25 (GenomeWeb News) - Glaxo SmithKline has licensed Jubilant Biosys' pathway database, Jubilant of Bangalore, India, said today.


Under the global license, Glaxo plans to use the database, PathArt, for its drug discovery research.


PathArt contains more than 1,200 signal-, metabolic-, and disease-specific pathways that have been manually curated. These pathways cover a number of diseases, including different types of cancer, arthritis, Alzheimer's disease, asthma, multiple sclerosis, Parkinson's disease, diabetes, and atherosclerosis.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.